"Erythromycin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A bacteriostatic antibiotic macrolide produced by Streptomyces erythreus. Erythromycin A is considered its major active component. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins.
| Descriptor ID |
D004917
|
| MeSH Number(s) |
D02.540.576.500.992
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Erythromycin".
Below are MeSH descriptors whose meaning is more specific than "Erythromycin".
This graph shows the total number of publications written about "Erythromycin" by people in this website by year, and whether "Erythromycin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 1 | 1 |
| 1999 | 0 | 1 | 1 |
| 2001 | 0 | 1 | 1 |
| 2004 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Erythromycin" by people in Profiles.
-
Erythromycin Use Before Induction of General Endotracheal Anesthesia. JAMA Surg. 2015 Aug; 150(8):738.
-
Identification of impurities in erythromycin by liquid chromatography-mass spectrometric detection. J Chromatogr A. 2004 Nov 12; 1056(1-2):111-20.
-
Treatment of severe pneumonia in kidney transplant recipients. Transplant Proc. 2001 Nov-Dec; 33(7-8):3652.
-
Prevalence and mechanisms of macrolide resistance in Streptococcus pyogenes in Santiago, Chile. Antimicrob Agents Chemother. 2001 Jan; 45(1):339-41.
-
Drug-induced disorders of the stomach and duodenum. Abdom Imaging. 1999 Jan-Feb; 24(1):9-16.
-
Gastroparesis as a cause of nausea and vomiting after high-dose chemotherapy and haemopoietic stem-cell transplantation. Lancet. 1998 Dec 19-26; 352(9145):1985.
-
Which form of erythromycin should be used to treat gastroparesis? A pharmacokinetic analysis. Aliment Pharmacol Ther. 1998 Apr; 12(4):373-6.
-
Evolving clinical problems with Streptococcus pneumoniae: increasing resistance to antimicrobial agents, and failure of traditional optochin identification in Chicago, Illinois, between 1993 and 1996. Diagn Microbiol Infect Dis. 1997 Dec; 29(4):209-14.
-
Antibiotic resistance: relationship to persistence of group A streptococci in the upper respiratory tract. Pediatrics. 1996 Jun; 97(6 Pt 2):971-5.
-
Erythromycin stearate as prokinetic agent in postvagotomy gastroparesis. Dig Dis Sci. 1990 Jul; 35(7):902-5.